Aliskiren versus lercanidipine in patients with hypertension uncontrolled with two classes of antihypertensives

Trial Profile

Aliskiren versus lercanidipine in patients with hypertension uncontrolled with two classes of antihypertensives

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Apr 2012

At a glance

  • Drugs Aliskiren (Primary) ; Lercanidipine (Primary) ; Antihypertensives
  • Indications Hypertension
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms ASPIV
  • Most Recent Events

    • 29 Apr 2012 Results presented at the 22nd European Meeting on Hypertension.
    • 11 Jul 2011 New trial record
    • 20 Jun 2011 Results presented at the 21st European Meeting on Hypertension.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top